Haematological Malignancies
Here below, you will find a list of all the latest content published on this website on the topic of Haematologic Malignancies. The content is published in chronological order. Find out more about our content categorisation .
-
« Previous
- 1
- 2
- ...
- 40
-
Next »
- 15th International Conference on Malignant Lymphoma 2019
- Understanding and Treating Lymphomas: The Challenges of a Curative Disease
- CLOSURE AND FAREWELL
- LAUDATIO: HENRY KAPLAN MEMORIAL LECTURE
- TAKE HOME MESSAGES
- 003 - THIRTY YEARS OF T-CELL LYMPHOMAS
- LAUDATIO: JOHN ULTMANN MEMORIAL LECTURE
- EB08 - RARE B CELL LYMPHOMAS IN CHILDREN AND ADOLESCENTS
- EB05 - HOW TO APPROACH CLL IN CLINICAL PRACTICE
- LAUDATIO: GIANNI BONADONNA MEMORIAL LECTURE
- 002 - PRECISION EPIGENETIC THERAPY FOR B-CELL LYMPHOMA
- EB01 - PCNSL, A CURABLE DISEASE
- EB04 - NEW TREATMENT OPTIONS IN HAIRY CELL LEUKEMIA WITH FOCUS ON BRAF INHIBITORS
- 001 - NEXT GENERATION CAR T CELLS FOR LYMPHOMA AND BEYOND
- EB15 - TREATMENT OF ELDERLY HODGKIN LYMPHOMA PATIENTS
- EB18 - NEW DRUGS FOR NEW TARGETS
- EB14 - RELAPSED AND REFRACTORY DISEASE
- EB17 - NEW DRUGS FOR OLD TARGETS
- EB16 - CAR T CELL THERAPY: FULL SPEED AHEAD
- EB13 - OPTIONS FOR FIRST LINE THERAPY OF HODGKIN LYMPHOMA
- EB02 - DOUBLE HIT LYMPHOMA, SO WHAT?
- EB06 - CUTANEOUS LYMPHOMAS
- EB11 - LIQUID BIOPSY IN NON HODGKIN'S LYMPHOMA
- EB03 - BREAST IMPLANT ASSOCIATED ALCL AND OTHER RARE T-CELL LYMPHOMAS
- EB07 - MANAGING THE TOXICITIES OF CAR T-CELL THERAPY
-
« Previous
- 1
- 2
- ...
- 40
-
Next »